Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Exactly. The company is going places, demand for these machines is off the scale.
The NHS contract was for less than one month’s supply of the Q16 and Q32 devices as well, which they have had to ramp up “five-fold”.
People need to stop worrying about NHS contracts and look at what is happening globally.
I would only expect something like today's press release to be RNSed by a £10m market cap company.
In much the same way that you don't see BP releasing an RNS every time they drill a well, but junior oilers RNS just that the drilling gear is on its way to a well!
NCYT is in the big leagues now. Multi hundred million pound contracts only.
Pretty muted rise really. Could see another 10-15% once the market wakes up.
The stream of RNS announcements shows that anyone with even the most tenuous link to Novacyt is backing up the truck on NCYT shares.
These are just the people who are actually following the rules and declaring it. There must be dozens of Primerdesign staff buying as much as they can afford in their ISAs because they know what's coming.
Han**** Holdings (Cayman) Inc. probably buying a few as well ;)
The pre-open price is the same as level 2 in the UK, it’s not actually trading and looking this early is pretty meaningless. I would expect them to have another shake early though so I’ve added a bit to my account to take advantage.
This doesn’t need an RNS to keep going up. All the technicals are pointing to £13-15 which it can do without any further news.
You can’t sit watching 10p moves in either direction any more, they are only 1 percent now.
The government has been introducing new technologies all through the pandemic but only RT-PCR has been standing the test of time. When was the last you heard about how successful the nudge box contract was?
The head of testing at Test and Trace has confirmed this morning on Twitter that there are no plans to move away from PCR testing in care homes, and as the Times article says the government is doubling the lighthouse lab capacity - all PCR again.
And we are still talking about just the UK.
Managed to add a good chunk at 740, first average up for me in quite a while.
Seems an absolute no brainer with contracts of greater value than the market cap but it took the market a while to realise last time and I am happy to take advantage while it works things out again.
I’m only 34 so I’ve got decades to pay off my mortgage. I don’t need to sell off my shares in what I believe is literally a once in a lifetime opportunity. Novacyt has one of, if not the, best tests for detecting infection of something that is causing a global pandemic.
I try to make a point of not bashing other shares Shaun but Avacta will be lucky if they get anything out this side of Easter. The government’s other forays into rapid tests have been a waste of public money but I do believe someone will crack a 100% specific lateral flow device. I just don’t believe it’s imminent and even if it was PCR has another year at least to run.
Similar boat, I could pay off my mortgage twice with what Novacyt has made me.
I finally told the wife last week and her advice was sell. Had I told her how well NCYT was doing a few months ago she’d have told me the same thing. We would be having a nice holiday instead of paying off the mortgage.
It’s very simple. In six months time do you think Novacyt will have sold a few more tests or a lot more tests?
That’s my reading, it’s just another £63m being spent on the original contract.
With all these big announcements it’s easy to forget that Novacyt are ticking along selling £30-40m per month on smaller contracts.
It’s mentioned here
https://ted.europa.eu/udl?uri=TED:NOTICE:467856-2020:TEXT:EN:HTML&src=0